Methylprednisolone Completed Phase 0 Trials for Friedreich's Ataxia Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT02424435Methylprednisolone Treatment of Friedreich Ataxia